IMDX - Latest News

Insight Molecular Diagnostics Inc. (IMDX), operates in Healthcare / Medical - Diagnostics & Research, trades on NASDAQ.

Market capitalization stands near $144.9M. Beta to the broader market is 1.77.

The article list below shows the most recent IMDX headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.

Recent IMDX Headlines

IMDx Chief Science Officer Ekkehard Schuetz Publishes 200th Research Paper

globenewswire.com - Jun 29, 2026

Key member of management ranks at top 2% of researchers in the field of laboratory diagnostics and top 2. 5% of all researchers worldwide, based on H-

iMDx and the American Society of Transplant Surgeons Announce Recipients of the ASTS-iMDx Health Economics Research Grant

globenewswire.com - Jun 22, 2026

-Grant Supports Health Economic Research Comparing In-House versus Send-Out dd-cfDNA Testing in Kidney Transplantation-

Favorable Head-to-Head Data on iMDx's GraftAssure with Competing NGS Assay Published in Clinical Chemistry

globenewswire.com - Jun 16, 2026

NASHVILLE, Tenn. , June 16, 2026 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc.

IMDX GraftAssure Assay Sets New Standard in Screening Kidney Transplant Patients Per American Journal of Transplantation

globenewswire.com - Jun 11, 2026

American Journal of Transplantation publishes public pre-proof showing novel CM-score superior to either fractional or absolute measurement of dd-cfDN

IMDX GraftAssure Assay Sets New Standard in Screening Kidney Transplant Patients Per American Journal of Transplantation

globenewswire.com - Jun 11, 2026

NASHVILLE, Tenn. , June 11, 2026 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc.

How News Affects IMDX Options Pricing

Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track IMDX's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.

Frequently asked IMDX news questions

What is the latest IMDX news headline?

The most recent IMDX headline (Jun 29, 2026) is "IMDx Chief Science Officer Ekkehard Schuetz Publishes 200th Research Paper". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.

How fresh is the IMDX news on this page?

News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.

What IMDX news moves options pricing?

Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.

How can I track unusual IMDX options activity related to news?

Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.